Clinical Trial Update: A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 open-label trial assessing feasibility and efficacy of switching advanced Parkinson's disease patients from pramipexole or ropinirole to rotigotine patc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)
• Pramipexole (pramipexole)
• Ropinirole (ropinirole)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Advanced Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-04-07